30 years on, CANTAB inventors herald the dawn of a new era in neuroscience

Delegates to CANTAB 30, a special conference held recently at the University of Cambridge to mark 30 years of expert cognitive neuroscience, heard how CANTAB™, has fundamentally changed the way brain function is measured and understood, leading to the dawn of a new era in neuroscience.Fittingly it was John Williams, Head of Neuroscience at The Wellcome Trust, who opened the event, stating that funding CANTAB all those years ago was “one of our best decisions.” Since its inception some 2,000 research studies have been published worldwide using CANTAB, which is now cited in over 160,000 scientific papers. CANTAB products are today used to enhance neuroscience research, accelerate the development of safe and effective therapeutics and improve cognitive health and wellbeing of the general population, particularly those at risk of dementia,…


Link to Full Article: 30 years on, CANTAB inventors herald the dawn of a new era in neuroscience